Elefante Mark B Has $2.01 Million Position in UnitedHealth Group Incorporated $UNH

Elefante Mark B increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,441 shares of the healthcare conglomerate’s stock after purchasing an additional 541 shares during the quarter. UnitedHealth Group makes up about 1.5% of Elefante Mark B’s portfolio, making the stock its 27th largest holding. Elefante Mark B’s holdings in UnitedHealth Group were worth $2,009,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in the stock. Bayforest Capital Ltd increased its position in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Kentucky Trust Co boosted its stake in shares of UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. O Brien Wealth Partners LLC boosted its stake in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after acquiring an additional 37 shares in the last quarter. Finally, Cloud Capital Management LLC bought a new position in UnitedHealth Group during the first quarter worth $53,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $358.80 on Tuesday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company’s 50-day moving average is $320.57 and its 200 day moving average is $346.99. The company has a market capitalization of $324.96 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same period last year, the company posted $6.80 earnings per share. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analysts Set New Price Targets

Several research analysts recently issued reports on UNH shares. Piper Sandler cut their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 30th. Royal Bank Of Canada dropped their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Oppenheimer dropped their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Bank of America raised their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday, October 8th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.